Department of Nutrition and Dietetics, Institute of Health, Jimma University, Jimma, Ethiopia
Department of Public Health, College of Medicine and Health Science, Werabe University, Werabe Ethiopia.
BMJ Open. 2024 Jun 11;14(6):e084033. doi: 10.1136/bmjopen-2024-084033.
OBJECTIVE: This systematic review and meta-analysis aimed to comprehensively assess the impact of weekly iron-folic acid supplementation (WIFAS) on the nutrition, health and educational outcomes of children and adolescents in sub-Saharan Africa. DESIGN: A systematic review and meta-analysis was used. DATA SOURCES: Five databases, namely, MEDLINE, Scopus, Web of Science, Cochrane Library and Google Scholar, were systematically searched for relevant articles up to 23 August 2023. ELIGIBILITY CRITERIA: It was focused on randomised controlled trials involving children and adolescents in sub-Saharan Africa, exploring the effects of iron supplementation on various outcomes, such as serum ferritin and haemoglobin levels, anaemia, mental health and school performance. DATA EXTRACTION AND SYNTHESIS: The Joanna Briggs Institute Critical Appraisal tools were used for quality assessment, with two independent reviewers thoroughly evaluating each paper. Using the Cochrane risk of bias tool, we evaluated the certainty of evidence such as the risk of bias, inconsistency, indirectness, imprecision and publication bias. RESULTS: A systematic review of 10 articles revealed that WIFAS significantly increased serum ferritin levels in adolescent girls (Hedge's g=0.53, 95% CI 0.28 to 0.78; heterogeneity I=41.21%, p<0.001) and haemoglobin levels in school-aged children (Hedge's g=0.37, 95% CI 0.01 to 0.73; heterogeneity I=91.62%, p<0.001). The analysis further demonstrated a substantial reduction in the risk of anaemia by 20% (risk ratio=0.8, 95% CI 0.69 to 0.93; heterogeneity I=28.12%, p<0.001). CONCLUSION: WIFAS proved effective in enhancing serum ferritin and haemoglobin concentrations and lowering the risk of anaemia in school-aged children and adolescents compared with a placebo. Similarly, there are not enough studies to examine the effects of WIFAS on school performance. However, information regarding mental health problems, mortality and potential side effects remains insufficient. PROSPERO REGISTRATION NUMBER: CRD42023397898.
目的:本系统评价和荟萃分析旨在全面评估每周补充铁叶酸(WIFAS)对撒哈拉以南非洲儿童和青少年的营养、健康和教育结果的影响。
设计:系统评价和荟萃分析。
资料来源:截至 2023 年 8 月 23 日,我们系统地检索了 5 个数据库,包括 MEDLINE、Scopus、Web of Science、Cochrane 图书馆和 Google Scholar,以查找相关文章。
纳入标准:研究对象为撒哈拉以南非洲的儿童和青少年,随机对照试验,探讨铁补充对血清铁蛋白和血红蛋白水平、贫血、心理健康和学业成绩等各种结局的影响。
数据提取与综合:采用 Joanna Briggs 研究所的批判性评估工具进行质量评估,由两名独立评审员对每篇论文进行全面评估。使用 Cochrane 偏倚风险工具评估证据的确定性,如偏倚风险、不一致性、间接性、不精确性和发表偏倚。
结果:对 10 篇文章进行系统评价后发现,WIFAS 显著提高了青春期少女的血清铁蛋白水平(Hedge's g=0.53,95%置信区间 0.28 至 0.78;异质性 I=41.21%,p<0.001)和学龄儿童的血红蛋白水平(Hedge's g=0.37,95%置信区间 0.01 至 0.73;异质性 I=91.62%,p<0.001)。分析还表明,贫血风险降低了 20%(风险比=0.8,95%置信区间 0.69 至 0.93;异质性 I=28.12%,p<0.001)。
结论:与安慰剂相比,WIFAS 可有效提高学龄儿童和青少年的血清铁蛋白和血红蛋白浓度,降低贫血风险。同样,目前还没有足够的研究来检验 WIFAS 对学业成绩的影响。然而,关于心理健康问题、死亡率和潜在副作用的信息仍然不足。
前瞻性注册:CRD42023397898。
Cochrane Database Syst Rev. 2022-2-1
Cochrane Database Syst Rev. 2024-8-15
Cochrane Database Syst Rev. 2024-12-13
Cochrane Database Syst Rev. 2021-9-26
Cochrane Database Syst Rev. 2019-1-31
Afr J Prim Health Care Fam Med. 2025-5-29
N Engl J Med. 2015-5-7
Neuropsychiatr Dis Treat. 2014-11-10